Journal Article

Epidemiology and economic burden of chronic heart failure

Andreas Bundkirchen and Robert H.G Schwinger

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 6, issue suppl_D, pages D57-D60
Published in print August 2004 | ISSN: 1520-765X
Published online August 2004 | e-ISSN: 1554-2815 | DOI:
Epidemiology and economic burden of chronic heart failure

Show Summary Details


Chronic heart failure is a major cause of morbidity and mortality in the general population. Both, the increasing age of the population and success in the treatment of patients with acute myocardial infarction rise the prevalence and thus the economic expenditures of chronic heart failure. This holds true despite recent improvement in survival of patients with congestive heart failure due to treatment with ACE inhibitors, β-adrenoceptor blockers and aldosterone antagonists. Chronic heart failure consumes 1–2% of the total healthcare resources in the industrialised countries with increasing tendency in future. The most effective approach for preventing heart failure is an improvement in diagnosis and consequent treatment of arterial hypertension. Evidence based treatment of congestive heart failure is both effective in lowering morbidity and mortality as well as cost-effective from an economic point of view.

Keywords: Heart failure; Epidemiology; Economics

Journal Article.  2610 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.